Abiopharma

🔍 WILLIS J KEVIN (Director)

Company: Ingevity Corp (NGVT)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 1,904 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,081.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents a grant of deferred stock units ("DSUs") issued pursuant to the reporting person's election to receive DSUs in lieu of the annual non-employee director restricted stock unit grant. These DSUs will vest on April 30, 2027 and will settle into an equal number of shares of the issuer's Common Stock upon the reporting person's termination of board service pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.